MedTherapy Biotech

MedTherapy is a Boston-based global biotechnology corporation manufacturing cell, gene and immunological therapies for treatment of cancer to make them accessible and affordable for every cancer patient in the world. MedTherapy works in collaboration with Harvard Medical School, Merck, and the International Health Organization (IHO) and many leading private and public instutions, organizations and biotechs. . Cell, gene and immunological therapies comprise the most sophisticated treatments modern technology has developed. While their success has been deemed a miracle, however, unfortunately, their cost is exorbitant often running into millions of dollars which is not sustainable for any individual patient, society or...

Cancer,immuno-oncology,gene therapy,cell therapy,immunology,immunotherapy,vaccines,oncology,rare diseases

Medtherapy biotech operates in the Biotechnology research industry.

Medtherapy biotech's revenue is 11m - 100m

Medtherapy biotech has 11 - 50 employees.